Back to search
Scientific Name: Zanubrutinib
Brand Name: Brukinsa
Company Owner: Not Available
Mechanism Of Action Bruton’s tyrosine kinase (BTK) is a non-receptor kinase and a signalling molecule for the B cell receptors expressed on the peripheral B cell surface.
Description of the Drug: Zanubrutinib is a kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from